Intratumoral administration of the Toll‐like receptor 7/8 agonist 3M‐052 enhances interferon‐driven tumor immunogenicity and suppresses metastatic spread in preclinical triple‐negative breast cancer
Damien Zanker(University of Melbourne), Belinda S. Parker(The University of Melbourne)
Cited by 37
Related Papers
JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression
|Cancers|2019|728
Neoadjuvant Interferons: Critical for Effective PD-1–Based Immunotherapy in TNBC
|Cancer Immunology Research|2017|80
Myoepithelial cell‐specific expression of stefin A as a suppressor of early breast cancer invasion
|The Journal of Pathology|2017|52